BioDrugs
Q1 Journal
Journal
Country
Switzerland
Western Europe
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Biotechnology
Q1
└
Medicine (miscellaneous)
Q1
└
Pharmacology
Q1
SJR 2025
2.628
Q1
SJR Score
H-Index
90
Citations / Doc (2yr)
8.60
Total Docs. (latest)
60
Total Citations (3yr)
1,474
Publication type
Journals
ISSN
11738804, 1179190X
Coverage
1996-2026
Journal Rank
#897
Subject Categories
Biotechnology
Q1
Medicine (miscellaneous)
Q1
Pharmacology
Q1
Pharmacology (medical)
Q1
Subject Areas
Aims & Scope
BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease.
The Journal includes:
- Definitive reviews on topics relating to the development and use of biotechnology in healthcare and the management of disease.
- Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.
- Original research articles on the clinical development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products.
- Leading/Current Opinion articles providing an overview of contentious or emerging issues and key regulatory and ethical issues.
- Adis Drug Evaluations reviewing the properties and place in therapy of biotechnology-based drugs.
- Adis Biosimilar Briefs summarizing key characteristics and clinical use of biosimilar drugs.
Abstracting & Indexing
Scopus
Google Scholar
Web of Science
Medline
Embase
Detailed Metrics
| Total Docs. (latest) | 60 |
| Total Docs. (3 years) | 169 |
| Total Refs. | 5,618 |
| Total Citations (3 years) | 1,474 |
| Citable Docs. (3 years) | 165 |
| Citations / Doc. (2 years) | 8.60 |
| Ref. / Doc. | 93.63 |
| % Female | 45.7% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.